The Role of Immunoassays in Early Disease Detection
Valued at USD 34.46 billion in 2025, the Immunoassay Market is projected to reach USD 36.03 billion in 2026 and USD 50.95 billion by 2034, growing at a CAGR of 4.4% during the forecast period 2026–2034. Key players include Abbott, BD, Beckman Coulter, Inc., bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QuidelOrtho Corporation, Siemens Healthineers AG, Sysmex...
0 Yorumlar 0 hisse senetleri 60 Views 0 önizleme
SocioMint https://sociomint.com